PMID: 3321540Oct 1, 1987Paper

Effect of sustained release terbutaline on symptoms and sleep quality in patients with nocturnal asthma

Thorax
I C StewartN J Douglas

Abstract

The effect of an oral sustained release beta 2 agonist on symptoms, sleep quality, and peak flow rates has been studied in nine patients with nocturnal asthma. Patients received oral terbutaline 7.5 mg twice daily or placebo for seven days in a double blind crossover study and spent the last two nights of each limb in a sleep laboratory. Oral terbutaline improved morning peak flow (259 v 213 l min-1) and decreased nocturnal inhaler usage (1.3 v 1.9) with no alteration in sleep quality as assessed electroencephalographically. The study shows that oral sustained release terbutaline can be useful in the treatment of nocturnal asthma without impairment of sleep quality.

References

Apr 1, 1977·British Journal of Diseases of the Chest·M Turner-Warwick
Jan 1, 1985·European Journal of Clinical Pharmacology·G H KoëterH Meurs
Dec 7, 1985·British Medical Journal·G B RhindD C Flenley
Jan 1, 1980·Acta Odontologica Scandinavica·E Asmussen

❮ Previous
Next ❯

Citations

Feb 1, 1993·Thorax·N J Douglas
Nov 14, 1997·American Journal of Respiratory and Critical Care Medicine·E J WeersinkD S Postma
Apr 1, 1990·The American Review of Respiratory Disease·N J Douglas, D C Flenley
Aug 27, 2014·Clinics in Chest Medicine·Wajahat H KhanCarolyn M D'Ambrosio
Jan 1, 1996·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·A R Van KeimpemaP E Postmus
Apr 29, 1998·Chest·R H MooreB F Dickey
Jan 1, 1990·Respiratory Medicine·C JansonB E Roos
Apr 29, 1998·Clinics in Chest Medicine·C M D'Ambrosio, V Mohsenin
Dec 1, 1993·The Annals of Pharmacotherapy·J M MeyerW A Kradjan
Jul 1, 1996·The Medical Clinics of North America·R Jokic, M F Fitzpatrick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.